Centiva Capital’s Avanos Medical AVNS Stock Holding History

Centiva Capital’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.24M	Buy	+50,000	New	+$1.17M	0.01%	546

Other funds holding AVNS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

NAM

Nexpoint Asset Management Dallas, Texas $1.5B AUM 83.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

TAL

TIG Advisors LLC New York $2.26B AUM 81.38% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

FTCM

First Trust Capital Management Chicago, Illinois $1.72B AUM 70.66% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Centiva Capital's AVNS Position: Q2 2026 in Review

Centiva Capital opened a new position in Avanos Medical (AVNS) in Q2 2026: 50,000 shares worth $1.24M. The stake represents 0.01% of the portfolio and ranks #545 among its holdings. This is a return to the name: Centiva Capital previously reported a position in AVNS as recently as Q3 2024.

Centiva Capital first reported a position in AVNS in Q3 2021 and has held it in 5 quarters since. 286 funds tracked by Wall St. Rank hold AVNS as of Q2 2026.

Centiva Capital held 50,000 shares of Avanos Medical worth $1.24M as of Q2 2026.
Avanos Medical was a new Centiva Capital position in Q2 2026.
Avanos Medical made up 0.01% of Centiva Capital's portfolio in Q2 2026, its #545 holding.
Centiva Capital first reported a position in Avanos Medical in Q3 2021 and has held it in 5 quarters since.
286 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2026.

Based on Centiva Capital's 13F filing for Q2 2026, filed 13 Aug 2026.